Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Series of Na+/Ca2+ exchange inhibitors for ischemic disorders from Taisho

Jan. 7, 1999

Vascular-selective potassium channel openers designed at Kanebo

Dec. 30, 1998

U.S. patent improves proprietary position of Alexion in C5 complement inhibition

Dec. 30, 1998

FDA gives go-ahead for first human study of VEGF-2 gene therapy

Dec. 30, 1998

Myocardial protective effects of JTV-519 demonstrated in isolated rat hearts

Dec. 30, 1998

Cardiovascular and Renal Drugs Advisory Committee meets in late January to discuss two NDAs

Dec. 29, 1998

Knoll and Hoechst Marion Roussel to codevelop treatment for CHF and hypertension

Dec. 23, 1998

Millennium delivers two additional drug targets for screening to Lilly

Dec. 23, 1998

Vesnarinone: adverse and favorable effects in CHF

Dec. 21, 1998

Abbott discloses discovery of selective ETA antagonist as potential backup compound to ABT-627

Dec. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...